메뉴 건너뛰기




Volumn 628, Issue 1-3, 2010, Pages 19-26

The dopaminergic stabilizers pridopidine (ACR16) and (-)-OSU6162 display dopamine D2 receptor antagonism and fast receptor dissociation properties

Author keywords

ACR16; Antipsychotic; Dopamine D2 receptor; Dopaminergic stabilizer; Fast dissociation; Pridopidine

Indexed keywords

3 [3 (METHYLSULFONYL)PHENYL] 1 PROPYLPIPERIDINE; ACR 16; AMISULPRIDE; APOMORPHINE; BIFEPRUNOX; CLOZAPINE; DOPAMINE; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR BLOCKING AGENT; HALOPERIDOL; N [[5 CHLORO 7 (METHYLSULFONYL) 2,3 DIHYDRO 1,4 BENZODIOXIN 2 YL]METHYL]ETHANAMINE; NS 30678; OLANZAPINE; PRIDOPIDINE; QUETIAPINE; QUINPIROLE; RACLOPRIDE; RISPERIDONE; UNCLASSIFIED DRUG;

EID: 73649139180     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.11.025     Document Type: Article
Times cited : (69)

References (43)
  • 2
    • 67349207461 scopus 로고    scopus 로고
    • Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects
    • Abi-Dargham A., van de Giessen E., Slifstein M., Kegeles L.S., and Laruelle M. Baseline and amphetamine-stimulated dopamine activity are related in drug-naïve schizophrenic subjects. Biol. Psychiatry 65 (2009) 1091-1093
    • (2009) Biol. Psychiatry , vol.65 , pp. 1091-1093
    • Abi-Dargham, A.1    van de Giessen, E.2    Slifstein, M.3    Kegeles, L.S.4    Laruelle, M.5
  • 3
    • 67349262381 scopus 로고    scopus 로고
    • Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotion
    • Benaliouad F., Kapur S., Natesan S., and Rompré P.-P. Effects of the dopamine stabilizer, OSU-6162, on brain stimulation reward and on quinpirole-induced changes in reward and locomotion. Eur. Neuropsychopharmacol. 19 (2009) 416-430
    • (2009) Eur. Neuropsychopharmacol. , vol.19 , pp. 416-430
    • Benaliouad, F.1    Kapur, S.2    Natesan, S.3    Rompré, P.-P.4
  • 4
    • 29244459436 scopus 로고    scopus 로고
    • The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behavior in Cebus paella monkeys
    • Brandt-Christensen M., Andersen M.B., Fink-Jensen A., Werge T., and Gerlach J. The substituted (S)-3-phenylpiperidine (-)-OSU6162 reduces apomorphine- and amphetamine-induced behavior in Cebus paella monkeys. J. Neural Transm. 113 (2006) 11-19
    • (2006) J. Neural Transm. , vol.113 , pp. 11-19
    • Brandt-Christensen, M.1    Andersen, M.B.2    Fink-Jensen, A.3    Werge, T.4    Gerlach, J.5
  • 6
    • 33646152528 scopus 로고    scopus 로고
    • A dopaminergic deficit hypothesis of scizophrenia: the path to discovery
    • Carlsson A., and Carlsson M.L. A dopaminergic deficit hypothesis of scizophrenia: the path to discovery. Dialogues Clin. Neurosci. 8 (2006) 137-142
    • (2006) Dialogues Clin. Neurosci. , vol.8 , pp. 137-142
    • Carlsson, A.1    Carlsson, M.L.2
  • 7
    • 1242329383 scopus 로고    scopus 로고
    • Schizophrenia: from dopamine to glutamate and back
    • Carlsson M.L., Carlsson A., and Nilsson M. Schizophrenia: from dopamine to glutamate and back. Curr. Med. Chem. 11 (2004) 267-277
    • (2004) Curr. Med. Chem. , vol.11 , pp. 267-277
    • Carlsson, M.L.1    Carlsson, A.2    Nilsson, M.3
  • 10
    • 0017255979 scopus 로고
    • Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs
    • Creese I., Burt D.R., and Snyder S.H. Dopamine receptor binding predicts clinical and pharmacological potencies of antischizophrenic drugs. Science 192 (1976) 481-483
    • (1976) Science , vol.192 , pp. 481-483
    • Creese, I.1    Burt, D.R.2    Snyder, S.H.3
  • 11
    • 0034681363 scopus 로고    scopus 로고
    • Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions
    • Ekesbo A., Andrén P.E., Gunne L.M., Sonesson C., and Tedroff J. Motor effects of (-)-OSU6162 in primates with unilateral 6-hydroxydopamine lesions. Eur. J. Pharmacol. 389 (2000) 193-199
    • (2000) Eur. J. Pharmacol. , vol.389 , pp. 193-199
    • Ekesbo, A.1    Andrén, P.E.2    Gunne, L.M.3    Sonesson, C.4    Tedroff, J.5
  • 12
    • 0023853769 scopus 로고
    • Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs
    • Farde L., Wiesel F.A., Halldin C., and Sedvall G. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. Arch. Gen. Psychiatry 45 (1988) 71-76
    • (1988) Arch. Gen. Psychiatry , vol.45 , pp. 71-76
    • Farde, L.1    Wiesel, F.A.2    Halldin, C.3    Sedvall, G.4
  • 14
    • 51149108773 scopus 로고    scopus 로고
    • Prolactin and dopamine: What is the connection?
    • Fitzgerald P., and Dinan T.G. Prolactin and dopamine: What is the connection?. J. Psychopharmacol. 22 (2008) 12-19
    • (2008) J. Psychopharmacol. , vol.22 , pp. 12-19
    • Fitzgerald, P.1    Dinan, T.G.2
  • 18
    • 0035660215 scopus 로고    scopus 로고
    • 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient
    • 2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient. Biol. Psychiatry 50 (2001) 873-883
    • (2001) Biol. Psychiatry , vol.50 , pp. 873-883
    • Kapur, S.1    Remington, G.2
  • 19
    • 0034109940 scopus 로고    scopus 로고
    • 2 receptors. Implications for atypical antipsychotic action
    • 2 receptors. Implications for atypical antipsychotic action. J. Psychiatry Neurosci. 25 (2000) 161-166
    • (2000) J. Psychiatry Neurosci. , vol.25 , pp. 161-166
    • Kapur, S.1    Seeman, P.2
  • 20
    • 0035094264 scopus 로고    scopus 로고
    • 2 receptor explain the action of atypical antipsychotics?: A new hypothesis
    • 2 receptor explain the action of atypical antipsychotics?: A new hypothesis. Am. J. Psychiatry 158 (2001) 360-369
    • (2001) Am. J. Psychiatry , vol.158 , pp. 360-369
    • Kapur, S.1    Seeman, P.2
  • 21
    • 0034025771 scopus 로고    scopus 로고
    • 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia
    • 2 occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. Am. J. Psychiatry 157 (2000) 514-520
    • (2000) Am. J. Psychiatry , vol.157 , pp. 514-520
    • Kapur, S.1    Zipursky, R.2    Jones, C.3    Remington, G.4    Houle, S.5
  • 26
    • 0036801619 scopus 로고    scopus 로고
    • PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's Disease
    • Nichols N.F., Cimini M.G., Hass J.V., Staton B.A., Tedroff J., and Svensson K.A. PNU-96391A (OSU6162) antagonizes the development of behavioral sensitization induced by dopamine agonists in a rat model for Parkinson's Disease. Neuropharmacology 43 (2002) 817-824
    • (2002) Neuropharmacology , vol.43 , pp. 817-824
    • Nichols, N.F.1    Cimini, M.G.2    Hass, J.V.3    Staton, B.A.4    Tedroff, J.5    Svensson, K.A.6
  • 27
  • 30
    • 44949208426 scopus 로고    scopus 로고
    • Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization
    • Rung J.P., Rung E., Helgeson L., Johansson A.M., Svensson K., Carlsson A., and Carlsson M.L. Effects of (-)-OSU6162 and ACR16 on motor activity in rats, indicating a unique mechanism of dopaminergic stabilization. J. Neural Transm. 115 (2008) 899-908
    • (2008) J. Neural Transm. , vol.115 , pp. 899-908
    • Rung, J.P.1    Rung, E.2    Helgeson, L.3    Johansson, A.M.4    Svensson, K.5    Carlsson, A.6    Carlsson, M.L.7
  • 32
    • 34547659151 scopus 로고    scopus 로고
    • Multiple dopamine functions at different time courses
    • Schultz W. Multiple dopamine functions at different time courses. Annu. Rev. Neurosci. 30 (2007) 259-288
    • (2007) Annu. Rev. Neurosci. , vol.30 , pp. 259-288
    • Schultz, W.1
  • 33
    • 0036221550 scopus 로고    scopus 로고
    • Atypical antipsychotics: mechanism of action
    • Seeman P. Atypical antipsychotics: mechanism of action. Can. J. Psychiatry 47 (2002) 27-38
    • (2002) Can. J. Psychiatry , vol.47 , pp. 27-38
    • Seeman, P.1
  • 34
    • 33846702551 scopus 로고    scopus 로고
    • Dopamine partial agonist action of (-)OSU6162 is consistent with dopamine hyperactivity in psychosis
    • Seeman P., and Guan H.-C. Dopamine partial agonist action of (-)OSU6162 is consistent with dopamine hyperactivity in psychosis. Eur. J. Pharmacol. 557 (2007) 151-153
    • (2007) Eur. J. Pharmacol. , vol.557 , pp. 151-153
    • Seeman, P.1    Guan, H.-C.2
  • 35
    • 0032973806 scopus 로고    scopus 로고
    • 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine
    • 2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. Am. J. Psychiatry 156 (1999) 876-884
    • (1999) Am. J. Psychiatry , vol.156 , pp. 876-884
    • Seeman, P.1    Tallerico, T.2
  • 36
    • 0017068246 scopus 로고
    • Antipsychotic drug doses and neuroleptic/dopamine receptors
    • Seeman P., Lee T., Chau-Wong M., and Wong K. Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature 261 (1976) 717-719
    • (1976) Nature , vol.261 , pp. 717-719
    • Seeman, P.1    Lee, T.2    Chau-Wong, M.3    Wong, K.4
  • 37
    • 0043269348 scopus 로고    scopus 로고
    • 3H]spiperone in isotonic medium: implications for human positron emission tomography
    • 3H]spiperone in isotonic medium: implications for human positron emission tomography. Synapse 49 (2003) 209-215
    • (2003) Synapse , vol.49 , pp. 209-215
    • Seeman, P.1    Tallerico, T.2    Ko, F.3
  • 39
    • 0028135190 scopus 로고
    • An efficient synthesis of the novel dopamine autoreceptor antagonist S-(-)-OSU6162, via palladium catalyzed cross-coupling reaction
    • Sonesson C., and Lindborg J. An efficient synthesis of the novel dopamine autoreceptor antagonist S-(-)-OSU6162, via palladium catalyzed cross-coupling reaction. Tetrahedron Lett. 35 (1994) 9063-9066
    • (1994) Tetrahedron Lett. , vol.35 , pp. 9063-9066
    • Sonesson, C.1    Lindborg, J.2
  • 40
    • 0027934781 scopus 로고
    • Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure- activity relationships
    • Sonesson C., Lin C.-H., Hansson L., Waters N., Svensson K., Carlsson A., Smith M.W., and Wikström H. Substituted (S)-phenylpiperidines and rigid congeners as preferential dopamine autoreceptor antagonists: synthesis and structure- activity relationships. J. Med. Chem. 37 (1994) 2735-2753
    • (1994) J. Med. Chem. , vol.37 , pp. 2735-2753
    • Sonesson, C.1    Lin, C.-H.2    Hansson, L.3    Waters, N.4    Svensson, K.5    Carlsson, A.6    Smith, M.W.7    Wikström, H.8
  • 41
    • 35348854954 scopus 로고    scopus 로고
    • Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912
    • Tadori Y., Kitagawa H., Forbes R.A., McQuade R.D., Stark A., and Kikuchi T. Differences in agonist/antagonist properties at human dopamine D2 receptors between aripiprazole, bifeprunox and SDZ 208-912. Eur. J. Pharmacol. 574 (2007) 103-111
    • (2007) Eur. J. Pharmacol. , vol.574 , pp. 103-111
    • Tadori, Y.1    Kitagawa, H.2    Forbes, R.A.3    McQuade, R.D.4    Stark, A.5    Kikuchi, T.6
  • 42
    • 0031913840 scopus 로고    scopus 로고
    • Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity
    • Tedroff J., Torstenson R., Hartvig P., Sonesson C., Waters N., Carlsson A., Neu H., Fasth K.-J., and Långström B. Effects of the substituted (S)-3-phenylpiperidine (-)-OSU6162 on PET measurements in subhuman primates: evidence for tone-dependent normalization of striatal dopaminergic activity. Synapse 28 (1998) 280-287
    • (1998) Synapse , vol.28 , pp. 280-287
    • Tedroff, J.1    Torstenson, R.2    Hartvig, P.3    Sonesson, C.4    Waters, N.5    Carlsson, A.6    Neu, H.7    Fasth, K.-J.8    Långström, B.9
  • 43
    • 0032693984 scopus 로고    scopus 로고
    • Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease
    • Tedroff J., Ekesbo A., Sonesson C., Waters N., and Carlsson A. Long-lasting improvement following (-)-OSU6162 in a patient with Huntington's disease. Neurology 53 (1999) 1605-1606
    • (1999) Neurology , vol.53 , pp. 1605-1606
    • Tedroff, J.1    Ekesbo, A.2    Sonesson, C.3    Waters, N.4    Carlsson, A.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.